Table 3.
Cost-effectiveness of Misoprostol and Oxytocin as Interventions to Prevent PPH Applied to 150,000 Deliveries
| Number of Referrals | Number of Referrals Averted | Total Cost (for 150,000 Births) | Change in Total Cost | ICER | |
|---|---|---|---|---|---|
| Outcome Measure: Referral to Higher-Level Facility | |||||
| Baseline | |||||
| Misoprostol | 74 | 4,666 | $331,758 | $181,758 | $38·96 |
| Oxytocin | 490 | 4,250 | $656,388 | $506,388 | $119·15 |
| SOC | 4,740 | 0 | $150,000 | ||
| Misoprostol Worst Case | |||||
| Misoprostol | 1,827 | 2,913 | $414,697 | $264,697 | $90·86 |
| Oxytocin | 186 | 4,554 | $525,110 | $375,110 | $82·37 |
| SOC | 4,740 | 0 | $150,000 | ||
| Misoprostol Best Case | |||||
| Misoprostol | 86 | 4,654 | $265,406 | $115,406 | $24·80 |
| Oxytocin | 3,129 | 1,611 | $820,485 | $670,485 | $416·29 |
| SOC | 4,740 | 0 | $150,000 | ||